PARP1 and prostate cancer: Barboro et al. showed that the expression and localization of poly (ADP-ribose) polymerase (PARP) in S/MARs was higher in PC3, an androgen-receptor-negative aggressive prostate cancer cell line, compared with LNCaP, an androgen-receptor-positive differentiated prostate cancer cell line.